NatPharm Crisis: US$10 Million Bailout Needed Amid Critical Medicine Shortages

Zimbabwe's NatPharm faces a severe financial crisis, urgently requiring a US$10 million bailout to avert critical medicine shortages. Health officials warn of supply chain compromise impacting public health access. This situation highlights government mismanagement and systemic governance failures. The potential collapse of NatPharm's supply chain could increase healthcare costs for businesses through higher insurance premiums or direct expenses, and lead to reduced employee productivity due to illness.